Tailoring an anti-cancer drug for optimal tumor cell killing
In a study published this week in Science, Université de Montreal researchers report key structural and biochemical differences among a class of anti-cancer drugs known as PARP inhibitors. These distinguishing differences ...
Apr 2, 2020
0
98